Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
VERV
Stock Latest News
The Fly
Verve Therapeutics reports new data from study of VERVE-201
23d ago
VERV
Press Releases
Verve Therapeutics Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates
23d ago
VERV
The Fly
Verve Therapeutics reports Q4 EPS (67c), consensus (76c)
24d ago
VERV
Press Releases
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
24d ago
VERV
The Fly
Verve Therapeutics: VERVE-101 awarded Innovation Passport by UK MHRA
1M ago
VERV
Press Releases
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia
1M ago
VERV
Stock Analysis & Ideas
2 High-Risk, High-Reward Stock Bets Cathie Wood Is Taking Into 2023
2M ago
NTLA
VERV
The Fly
Verve Therapeutics initiated with a Neutral at Cantor Fitzgerald
2M ago
VERV
The Fly
Sell these stocks now, proven algorithm says
3M ago
GH
CCL
The Fly
Short Report: Bears pounce on disappointing drug news from Gossamer and Verve
3M ago
RAD
GOSS
The Fly
Verve Therapeutics initiated with a Sell at Goldman Sachs
3M ago
VERV
Market News
Verve Plunges After FDA Clinical Hold
4M ago
VERV
The Fly
Verve FDA request ‘provides fodder for both bulls and bears,’ says Stifel
4M ago
VERV
The Fly
Verve Therapeutics receives information from FDA regarding clinical hold
4M ago
VERV
The Fly
Beam hold being lifted ‘encouraging’ for Verve Therapeutics, says Guggenheim
4M ago
BEAM
VERV
Press Releases
Verve Therapeutics to Participate in Upcoming Investor Conferences
4M ago
VERV
Market News
Verve Therapeutics Nosedives after Q3 Loss; FDA Hold on VERVE-101
5M ago
VERV
Stock Analysis & Ideas
Cathie Wood Doubles Down on These 2 Innovation Stocks
5M ago
PATH
VERV
Press Releases
Verve Therapeutics to Participate in Upcoming Investor Conferences
6M ago
VERV
Press Releases
Verve Therapeutics Announces Clearance of Clinical Trial Authorisation Application by the United Kingdom Medicines and Healthcare Products Regulatory Agency for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia
6M ago
VERV
Press Releases
Verve Therapeutics Highlights Preclinical Data Supporting Nomination of VERVE-201 ANGPTL3 Product Candidate at the European Society of Cardiology 2022 Congress
7M ago
VERV
Press Releases
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
8M ago
VERV
Stock Analysis & Ideas
Billionaire Leon Cooperman Thinks Stocks Are More Attractive Than Bonds Right Now; Here Are 2 Names Analysts Like
9M ago
STKL
VERV
Press Releases
Verve Therapeutics Doses First Human with an Investigational In Vivo Base Editing Medicine, VERVE-101, as a Potential Treatment for Heterozygous Familial Hypercholesterolemia
9M ago
VERV
Press Releases
Verve Therapeutics Appoints Experienced Biotechnology Executive, Alexander G. “Bo” Cumbo, to its Board of Directors
10M ago
VERV
Press Releases
Verve Therapeutics to Participate in the 2022 Jefferies Healthcare Conference
10M ago
VERV
You need to enable JavaScript to run this app.
